Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dasatinib reversibly disrupts endothelial vascular integrity by increasing non-muscle myosin II contractility in a ROCK-dependent manner

  • Kreutzman, Anna
  • Colom-Fernández, Beatriz
  • Marcos Jiménez, Ana
  • Ilander, Mette
  • Cuesta-Mateos, Carlos
  • Pérez-García, Yaiza
  • Delgado Arévalo, Cristina
  • Brück, Oscar
  • Hakanen, Henna
  • Saarela, Jani
  • Ortega-Carrión, Alvaro
  • Rosendo, Ana de
  • Juanes-García, Alba
  • Steegmann, Juan Luis
  • Mustjoki, Satu
  • Vicente-Manzanares, Miguel
  • Muñoz-Calleja, Cecilia
[Purpose]: Dasatinib is a short-acting dual ABL/SRC family tyrosine kinase inhibitor (TKI), which is frequently used to treat chronic myeloid leukemia. Although very effective, patients taking dasatinib often display severe adverse effects, including pleural effusions and increased risk of bleeding primarily in the gastrointestinal tract. The actual causes of these side effects are currently undetermined. We hypothesize that endothelial cells (ECs) that line the inner walls of blood vessels and control the traffic to the underlying tissues might be involved. [Experimental Design]: The effects of TKIs on ECs were studied by various assays, such as real-time cell impedance measurements, live-cell microscopy, wound healing, Western blot, and an in vivo model. [Results]: Dasatinib uniquely causes a profound, dose-dependent disorganization of the EC monolayers. Dasatinib promoted the disassembly of cell–cell contacts, altered cell–matrix contacts, and further altered the wound healing. A key observation is that this effect is fully reversible after drug washout. In line with these in vitro observations, intraperitoneal administration of dasatinib to mice caused significant vascular leakage in the intestine. The underlying molecular mechanism of dasatinib-induced reorganization of the actin involves ROCK activation, which increases the amount of the phosphorylation of myosin light chain and consequently activates the non-muscle myosin II. [Conclusions]: Our data are consistent with a scenario in which dasatinib triggers a transient increase in vascular leakage that probably contributes to adverse effects such as bleeding diathesis and pleural effusions., A. Kreutzman is a Sigrid Jusélius postdoctoral fellow. Grants PI12/00494P and PI15/02085 from the Fondo de Investigaciones Sanitarias to C. Muñoz-Calleja supported this work. C. Muñoz-Calleja was co-financed by FEDER funds. M. Vicente-Manzanares is an investigator from the Ramon y Cajal Program (RYC-2010-06094) and is supported by grants SAF2014-54705-R from MINECO, Marie Curie CIG-293719 from the EU, CIVP16A1831 from Ramon Areces Foundation and the BBVA Foundation. S. Mustjoki is supported by the Finnish Cancer Institute, Academy of Finland, Sigrid Juselius Foundation and Finnish Cancer Associations., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A regulatory motif in nonmuscle myosin II-B regulates its role in migratory front-back polarity

  • Juanes-García, Alba
  • Chapman, Jessica R.
  • Aguilar-Cuenca, Rocio
  • Delgado Arévalo, Cristina
  • Hodges, Jennifer
  • Whitmore, Leanna A.
  • Shabanowitz, Jeffrey
  • Hunt, Donald F.
  • Horwitz, Alan Rick
  • Vicente-Manzanares, Miguel
In this study, we show that the role of nonmuscle myosin II (NMII)-B in front-back migratory cell polarity is controlled by a short stretch of amino acids containing five serines (1935-1941). This motif resides near the junction between the C terminus helical and nonhelical tail domains. Removal of this motif inhibited NMII-B assembly, whereas its insertion into NMII-A endowed an NMII-B-like ability to generate large actomyosin bundles that determine the rear of the cell. Phosphomimetic mutation of the five serines also inhibited NMII-B assembly, rendering it unable to support front-back polarization. Mass spectrometric analysis showed that several of these serines are phosphorylated in live cells. Single-site mutagenesis showed that serine 1935 is a major regulatory site of NMII-B function. These data reveal a novel regulatory mechanism of NMII in polarized migrating cells by identifying a key molecular determinant that confers NMII isoform functional specificity., This work is supported by grants SAF2011-24953 from MINECO, FP7 Marie Curie CIG-293719 from the EU, CIVP16A1831 from the Ramon Areces Foundation (M. Vicente-Manzanares), GM 23244 (A.R. Horwitz), GM037537 (D.F. Hunt), and the Cell Migration Consortium U54 GM64346 (A.R. Horwitz and D.F. Hunt). M. Vicente-Manzanares is an investigator from the Ramón y Cajal Program (RYC-2010-06094)., Peer Reviewed